UK Competition Watchdog Has Concerns About Stryker/Wright Medical Merger

Jul 01 2020

• By Phil Greenfield

Listen to this article

The UK Competition and Markets Authority has concerns over the impact on the market for ankle replacements that would result from Stryker's planned $4bn acquisition of Wright Medical.

Magnifier — • Source: Shutterstock

The UK Competition and Markets Authority (CMA) has said that if Stryker Corp.’s purchase of Wright Medical Group NV went ahead, it would have a negative impact on patients in the UK who need ankle replacements. Following an initial investigation, the CMA found that the proposed merger would result in the combined company having a share of over 90% of the total ankle replacement prostheses market in the UK.

CMA senior director Joel Bamford said: “The CMA is concerned that this merger and the resulting reduction in competition could...

More from United Kingdom

Global Medtech Guidance Tracker: September 2024
Oct 02 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK
Sep 18 2024
• By Natasha Barrow
UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.
Abbott’s Share-Gobbling Aveir DR Leadless Pacing System Introduced To UK
Sep 13 2024
• By Natasha Barrow
The firm’s dual-chamber leadless pacemaker system with is expected to be a growth driver for Abbott and already has acquired approximately 30%-40% of market share from Medtronic since its approval by the US FDA in July 2023, according to GlobalData.
Global Medtech Guidance Tracker: August 2024
Sep 03 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Nearly 80 documents have been posted on the tracker since its last update.

More from Europe

Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK
Sep 18 2024
• By Natasha Barrow
UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.
Abbott’s Share-Gobbling Aveir DR Leadless Pacing System Introduced To UK
Sep 13 2024
• By Natasha Barrow
The firm’s dual-chamber leadless pacemaker system with is expected to be a growth driver for Abbott and already has acquired approximately 30%-40% of market share from Medtronic since its approval by the US FDA in July 2023, according to GlobalData.
Amferia Aims To Bring Peptide Hydrogel To Fight Against Antimicrobial Resistance
Sep 04 2024
• By Natasha Barrow
Amferia is developing an antimicrobial peptide hydrogel dressing to combat infections in acute wounds in humans and veterinary contexts. Supported by €1.2m of new venture capital financing, the company is planning pivotal clinical studies to support an FDA application later this year and CE mark submission in 2026-2027.